Zealand Pharma’s drug for rare metabolic disease smashes phase III
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
Evotec and Sernova are set to join forces to advance a beta cell replacement therapy…
The UK company F2G Ltd. has announced a strategic collaboration with Japanese pharmaceutical company Shionogi…
Following our recent acquisition by Inova, our team is expanding! We’re very excited to welcome…
As biotech investment slows following a record-breaking year, the Paris-based Sofinnova Partners has landed a…
During drug development, biologics often fail to transition from the preclinical to the clinical stage,…
The stock price of the French Covid-19 vaccine maker Valneva has been knocked down by…
The cosmetics industry is looking for greener ingredients as consumers demand more sustainable products. According…
Domain Therapeutics, a biopharmaceutical company in France and Canada developing cancer immunotherapies targeting G protein-coupled…
Private biotech investments in Europe were on a steady decline in April 2022 as biotech…
The French startup creator eureKARE has set up a special purposes acquisition company (SPAC) with…
Large-panel cancer cell line screening can help find the right fit between a specific cancer…